SCHEMBL6132034

SCHEMBL6132034

CN(C)c1ccc(-c2cn[nH]c2-c2ccccc2Cl)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.49
POLB P06746 1/20 0.49
PIK3CA P42336 3/20 0.47
TRPA1 O75762 1/20 0.43
RPS6KA3 P51812 4/20 0.43
TGFBR1 P36897 3/20 0.43
HTR7 P34969 1/20 0.43
MAPT P10636 3/20 0.43
HSD17B10 Q99714 2/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
GAA P10253 1/20 0.43
HPGD P15428 1/20 0.43
TSHR P16473 1/20 0.43
CASP1 P29466 1/20 0.43
CASP7 P55210 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
PIK3CD O00329 1/20 0.42
GYS1 P13807 1/20 0.42
PIK3CB P42338 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14519450 0.79 RPS6KA3 (0.66) KMT2APOLBPIK3CATRPA1RPS6KA3
SCHEMBL6132074 0.71 PIK3CA (0.47) KMT2APOLBPIK3CATRPA1RPS6KA3
SCHEMBL6132047 0.70 KMT2A (0.57) KMT2ATGFBR1HTR7MAPTKDM4E
SCHEMBL4171344 0.70 MAPT (0.60) MAPTHSD17B10KDM4EALDH1A1GAA
SCHEMBL19698857 0.70 ALDH1A1 (0.58) KMT2AMAPTHSD17B10KDM4EALDH1A1
SCHEMBL8212313 0.67 MAPT (0.45) KMT2AMAPTHSD17B10KDM4EALDH1A1
SCHEMBL9488910 0.67 NR4A2 (0.49) KMT2AMAPTHSD17B10KDM4EALDH1A1
SCHEMBL16837157 0.66 ALDH1A1 (0.52) KMT2AMAPTHSD17B10KDM4EALDH1A1
SCHEMBL12844173 0.66 POLB (0.49) KMT2APOLBPIK3CATRPA1HTR7
SCHEMBL5248907 0.65 RPS6KA3 (0.81) KMT2ARPS6KA3TGFBR1HSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1435957-A4 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3BETA PROTEIN AND PROTEIN COMPLEXES VERTEX PHARMA (US) 2005-04-13 EP claimed
EP-1435957-A2 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3BETA PROTEIN AND PROTEIN COMPLEXES Vertex Pharmaceuticals Incorporated (US) 2004-07-14 EP claimed
WO-2002088078-A2 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3β PROTEIN AND PROTEIN COMPLEXES VERTEX PHARMACEUTICALS INCORPORATED (US) 2002-11-07 WO claimed